Actively Recruiting
Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer
Led by Origin Sciences · Updated on 2025-04-04
6600
Participants Needed
1
Research Sites
125 weeks
Total Duration
On this page
Sponsors
O
Origin Sciences
Lead Sponsor
S
Shrewsbury and Telford Hospitals NHS Trust
Collaborating Sponsor
AI-Summary
What this Trial Is About
Development of a multiomics assay for use on OriColTM sampled rectal mucus for detection of cancer and significant polyps in symptomatic patients on the Colorectal Urgent Suspected Cancer pathway.
CONDITIONS
Official Title
Triple Assay of Rectal Mucus in the Diagnosis of Colorectal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients 18 years and over
- Patients referred from primary care to the urgent suspected cancer colorectal cancer pathway during the study period
- Patients who provide voluntary written informed consent to participate in the study
You will not qualify if you...
- Patients unable to undergo digital rectal examination
- Patients with peri-anal or anal symptoms limiting examination, including those who have undergone radiotherapy, have acute or chronic anal fissure, perianal hematoma, acute thrombosed hemorrhoids, post-operative anal stenosis, obstructing anal/low rectal tumor, or discomfort from previous pelvic radiotherapy
- Current pregnancy or suspicion of pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Shrewsbury & Telford NHS Foundation Trust
Telford, Shropshire, United Kingdom, TF33DD
Actively Recruiting
Research Team
J
Jon Lacy-Colson, FRCS
CONTACT
I
Ian Daniels, FRCS
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here